Drug Development Pharma - January 23, 2014
EU approval for new diabetes treatment
AstraZeneca and Bristol-Myers Squibb treatment for type 2 diabetes Xigduo has been granted Marketing Authorization by the European Commission. Xigduo, which has the trade name Forxiga, combines dapagliflozin, a selective and reversible inhibitor of SGLT2 with metformin hydrochloride, two anti-hyperglycaemic products with complementary mechanisms of action to improve glycaemic control. This is the first regulatory approval for a […]
Career choice - January 15, 2014
Project Director
In his job as Project Director at AstraZeneca’s Pharmaceutical Development unit, Anders Holmén constantly has to be one step ahead and has to be able to see how science best can benefit the end customer.
Nobel Prize Laureate - December 20, 2013
Randy Schekman: From dreams to yeast
Randy Schekman’s discoveries using yeast to determine the movement of vesicles brought his Nobel Prize dreams to life.
Nobel Prize Laureate - December 20, 2013
Martin Karplus: An observer of life
The curiosity to understand the surrounding world has led Martin Karplus to a lifelong love for science, food and photography.
Nobel Prize Laureate - December 20, 2013
Michael Levitt: A scientist young at heart
Michael Levitt is a pioneer in computational biology who is as passionate as ever about science and life.
Nobel Prize Laureate - December 20, 2013
Thomas Südhof: Solving the mysteries of nerve cells
Thomas Südhof has provided invaluable insight into the workings of the brain and communication of the nerve cells.
